Sustained exposure to pathological stress stimulates the heart to hypertrophy, increasing disease and mortality risk. New therapies to blunt this process include targeting enzymes below the cell ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...

Left ventricular hypertrophy (LVH) is an abnormal thickening of the left ventricular myocardium that occurs as an adaptive mechanism to increased afterload. The left ventricular myocytes ...

Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, and hypertension. Pharmaceuticals play a crucial role in addressing these ...

Another active area of research in the laboratory focuses on unraveling the mechanisms behind maladaptive, or pathological, and adaptive, or physiological, cardiac hypertrophy. In response to certain ...

A 36-year-old man died last fall at the Spokane County Jail from a heart problem, according to the Spokane County Medical ...

Right ventricular hypertrophy occurs when the right ventricular wall thickens due to chronic pressure overload, similar to that of left ventricular hypertrophy. RVH is diagnosed on ECG in the ...

Cardiac hypertrophy, characterized by the thickening of the heart muscle, is a significant risk factor for heart failure and other cardiovascular diseases. Recent research has increasingly focused ...

Aldosterone has been shown to cause coronary inflammation, cardiac hypertrophy, myocardial fibrosis, ventricular arrhythmias, and ischemic and necrotic lesions. There are currently two aldosterone ...

Cytokinetics, Inc. (CYTK), a biopharmaceutical company focused on muscle biology, on Monday announced the launch of the AMBER-HFpEF ...